News

3-D ‘Scaffolds’ Supporting Healthy Neurons Offer New Stem Cell-Treatment Approach for Parkinson’s

Rutgers and Stanford University researchers have developed 3-D “scaffolds,” or fibers, that can support healthy and high-functioning human neurons derived from adult stem cells, which can be transplanted to the brain to replace diseased neurons. The technology represents a possible new therapeutic strategy for numerous neurological conditions, including Parkinson’s and Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple…

CONy16: AbbVie’s DUOPA Pump Continues to Show Efficacy as Parkinson’s Treatment; Exclusive Interview with a Lead Researcher

Multinational research-based biopharmaceutical company AbbVie‘s product DUOPA is a fresh approach to the administration of carbidopa and levodopa for the treatment of motor fluctuations that afflict people with advanced Parkinson’s disease. A researcher, in an exclusive interview with Parkinson’s News Today at the recent  10th World Congress on…